Red Nucleus (Riverside-backed) Acquires iTakeControl
March 4, 2021
Red Nucleus, a Riverside-backed provider of learning and performance solutions for life sciences, has acquired iTakeControl, a mobile platform that collects patient-reported outcomes and real-world data for virtual and home-based clinical trials. The transaction, announced in March 2021, is an add-on to Riverside’s Red Nucleus platform to expand virtual clinical trial and SaaS capabilities for rare disease and specialty pharma clients.
- Buyers
- Red Nucleus, The Riverside Company
- Targets
- iTakeControl
- Platforms
- Red Nucleus
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company
October 17, 2024
Healthcare Services
THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.
-
Red Nucleus (RN) / Riverside Acquire AlphaGroup Medical Communications
December 12, 2022
Healthcare Services
Red Nucleus (RN), a portfolio company of The Riverside Company, has acquired AlphaGroup Medical Communications, LLC as an add-on to RN's medical communications business unit. The acquisition expands RN's publications, medical affairs and HEOR/RWE capabilities and brings AlphaGroup's therapeutic expertise and scientific staff into the combined business.
-
Riverside's Red Nucleus Adds Actando SA
June 13, 2022
Healthcare Services
The Riverside Company’s Red Nucleus platform has completed an add-on acquisition of Actando SA, a Switzerland-headquartered provider of technology-enabled learning solutions for life sciences commercial teams. The deal expands Red Nucleus’ learning product portfolio and European footprint, strengthening its offering of scalable LMS, eLearning content and decision-making tools for global biopharma customers.
-
Red Nucleus / Riverside Acquire INVIVO Communications
September 30, 2020
Healthcare Services
Red Nucleus, the life-sciences learning and performance platform backed by The Riverside Company, acquired Toronto-based INVIVO Communications, a digital scientific communications agency. The deal is an add-on to Riverside's Red Nucleus platform, expanding RN's medical communications and digital scientific communications capabilities; the combined business now totals 360+ employees across seven locations.
-
Red Nucleus (backed by The Riverside Company) Acquires Life Science Training Institute (LSTI)
September 14, 2020
Healthcare Services
Red Nucleus, a life-sciences learning and training platform backed by The Riverside Company, acquired Life Science Training Institute (LSTI), a provider of on-demand, live, and custom compliance training for pharmaceutical, biotech and medical device customers. The add-on transaction (closed September 2020) expands Red Nucleus's R&D e-learning and compliance capabilities and brings LSTI's subscription library of over 200 courses into RN's platform.
-
The Riverside Company Acquires Red Nucleus from Renovus Capital Partners
March 24, 2020
Education
The Riverside Company has acquired Red Nucleus Enterprises, LLC, a Yardley, Pennsylvania-based provider of digital learning and regulatory compliance services for the life sciences industry. Renovus Capital Partners sold the company to Riverside but retained a minority equity stake and will continue to support future growth; Riverside plans to expand Red Nucleus's training offerings, technology capabilities and pursue add-on acquisitions.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.